Added to YB: 2017-10-25
Pitch date: 2017-10-25
RYTM:US [bullish]
Rhythm Pharmaceuticals, Inc.
+211.64%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.
Market Cap
$6.4B
Pitch Price
$28.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
-32.16
P/E
-29.86
EV/Sales
29.05
Sector
Biotechnology
Category
N/A
Show full summary:
Rhythm Pharmaceuticals, Inc. RYTM:US
A summary for this pitch has not been created yet.
Read full article (0 min)